CA2415808A1 - Transporters and ion channels - Google Patents

Transporters and ion channels Download PDF

Info

Publication number
CA2415808A1
CA2415808A1 CA002415808A CA2415808A CA2415808A1 CA 2415808 A1 CA2415808 A1 CA 2415808A1 CA 002415808 A CA002415808 A CA 002415808A CA 2415808 A CA2415808 A CA 2415808A CA 2415808 A1 CA2415808 A1 CA 2415808A1
Authority
CA
Canada
Prior art keywords
polynucleotide
seq
polypeptide
amino acid
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002415808A
Other languages
English (en)
French (fr)
Inventor
Brigitte E. Raumann
Michael Thornton
Li Ding
Henry Yue
Y. Tom Tang
Lee Harland
Neil Burford
Barrie D. Greene
Madhusudan S. Sanjanwala
Mariah R. Baughn
Monique G. Yao
Junming Yang
Chandra S. Arvizu
Ameena R. Gandhi
April J. A. Hafalia
Catherine M. Tribouley
Narinder K. Chawla
Janice Au-Young
Roderick T. Walsh
Jayalaxmi Ramkumar
Yan Lu
Dyung Aina M. Lu
Yalda Azimzai
Preeti Lal
Vicki S. Elliott
Danniel B. Nguyen
Yuming Xu
Jeffrey J. Seilhamer
Mark L. Borowsky
Farrah A. Khan
Liam Kearney
Kavitha Thangavelu
Debopriya Das
Jennifer L. Policky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2415808A1 publication Critical patent/CA2415808A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002415808A 2000-07-07 2001-07-05 Transporters and ion channels Abandoned CA2415808A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US21654700P 2000-07-07 2000-07-07
US60/216,547 2000-07-07
US21823200P 2000-07-14 2000-07-14
US60/218,232 2000-07-14
US22011200P 2000-07-21 2000-07-21
US60/220,112 2000-07-21
US22183900P 2000-07-28 2000-07-28
US60/221,839 2000-07-28
PCT/US2001/021448 WO2002004520A2 (en) 2000-07-07 2001-07-05 Transporters and ion channels

Publications (1)

Publication Number Publication Date
CA2415808A1 true CA2415808A1 (en) 2002-01-17

Family

ID=27499045

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002415808A Abandoned CA2415808A1 (en) 2000-07-07 2001-07-05 Transporters and ion channels

Country Status (5)

Country Link
EP (1) EP1313854A2 (ja)
JP (1) JP2004513618A (ja)
AU (1) AU2001273239A1 (ja)
CA (1) CA2415808A1 (ja)
WO (1) WO2002004520A2 (ja)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236389A1 (en) * 2000-12-15 2003-12-25 Shimkets Richard A. Proteins, polynucleotides encoding them and methods of using the same
US6586179B1 (en) * 1999-07-13 2003-07-01 Icagen, Incorporated Human Eag2
WO2001057214A2 (en) * 2000-02-03 2001-08-09 Lexicon Genetics Incorporated Human transporter proteins and polynucleotides encoding the same
US20020132298A1 (en) * 2000-11-14 2002-09-19 Millennium Pharmaceuticals, Inc. 67118, 67067, and 62092, human proteins and methods of use thereof
US20020042100A1 (en) * 2000-07-03 2002-04-11 Chunhua Yan Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof
AU2001293100A1 (en) * 2000-09-25 2002-04-02 Millennium Pharmaceuticals, Inc. 49938, a human phospholipid transporter and uses therefor
GB2372503A (en) * 2000-10-19 2002-08-28 Glaxo Group Ltd Voltage-gated potassium channel polypeptides
EP1517917A4 (en) * 2000-11-20 2005-10-12 Merck & Co Inc HUMAN ERG2 KALIUM CHANNEL
US20020103337A1 (en) * 2000-12-04 2002-08-01 Chunhua Yan Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
UA79927C2 (en) * 2000-12-05 2007-08-10 Serono Genetics Inst Sa Polynucleotide, coding a polypeptide of potential-depending portal ionic human channel (canion), polypeptyde, antibody, method for identification of candidate modulator of canion-polypeptyde, method for treatment of bipolar disorder or schizophrenia and use of an antibody for production of drugs for treatment of schizophrenia or bipolar disorder
AU2002239573A1 (en) * 2000-12-12 2002-06-24 Pe Corporation (Ny) Human transporter proteins, nucleic acid molecules encoding them, and uses thereof
EP1358196A4 (en) * 2000-12-20 2004-11-03 Merck & Co Inc HUMAN HYPERPOLARIZATION-ACTIVATED, CYCLIC NUCLEOTIDE-CONTROLLED CATION CHANNEL HCN3
JP3997912B2 (ja) * 2000-12-27 2007-10-24 アステラス製薬株式会社 新規カリウムチャネル
US20040185527A1 (en) * 2001-01-22 2004-09-23 Gennady Merkulov Isolated human transporter proteins nucleic acid molecules encoding human transporter proteins and uses thereof
EP1273660A3 (en) * 2001-01-30 2004-01-07 Aeomica, Inc. Human sodium-hydrogen exchanger like protein 1
GB2390093A (en) * 2001-01-30 2003-12-31 Aeomica Inc Human sodium-hydrogen exchanger like protein 1
US20020142378A1 (en) * 2001-03-21 2002-10-03 Hongyu Zhang Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
GB2377445A (en) * 2001-04-20 2003-01-15 Smithkline Beecham Plc Ion channel vanilloid receptor, VANILREP7
EP1258496A1 (en) * 2001-05-09 2002-11-20 Millenium Pharmaceuticals, Inc. 63751, Human sugar tranporter family member and uses therefor
WO2002101035A1 (fr) * 2001-05-10 2002-12-19 Mochida Pharmaceutical Co., Ltd. Proteine du canal cation dependant du potentiel
EP1456397A4 (en) * 2001-07-10 2005-05-11 Millennium Pharm Inc 52908, A HUMAN CALIUM CHANNEL, AND USES THEREOF
US20030044933A1 (en) * 2001-08-15 2003-03-06 Millennium Pharmaceuticals, Inc. 96895, a human sodium-hydrogen exchanger family member and uses therefor
WO2003038094A1 (en) * 2001-10-30 2003-05-08 Bayer Healthcare Ag Regulation of human glucose transporter
WO2003037929A1 (en) * 2001-11-01 2003-05-08 Bayer Healthcare Ag Polynucleotides encoding human potassium channel polypeptides
WO2003054190A1 (fr) * 2001-12-21 2003-07-03 Takeda Chemical Industries, Ltd. Nouvelles proteines et adn correspondants
WO2003056005A1 (fr) * 2001-12-27 2003-07-10 Takeda Chemical Industries, Ltd. Promoteur homologue de sglt humain et utilisation dudit promoteur
EP1473303B1 (en) 2002-01-18 2010-02-24 Takeda Pharmaceutical Company Limited Sodium dependent bile acid transporter and use thereof
AU2003226797A1 (en) * 2002-04-16 2003-10-27 Bayer Healthcare Ag Regulation of human transient receptor potential channel
US20060063711A1 (en) * 2002-10-29 2006-03-23 Keiji Iwamoto Use of sglt homolog
US7338781B2 (en) 2003-03-10 2008-03-04 Bayer Healthcare Ag Organic anion transporting (oat)-like protein UST3-LIKE1 and uses thereof
WO2005029086A2 (en) * 2003-09-22 2005-03-31 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with organic cation transporter slc22a10 (ust3-like2) (slc22a10)
WO2011035386A1 (en) * 2009-09-25 2011-03-31 Australian Centre For Plant Functional Genomics Pty Ltd Cation channel activity
CA3187837A1 (en) * 2020-08-04 2022-02-10 Exelixis, Inc. Cd47 binding agents and uses thereof
CN115322248B (zh) * 2022-05-18 2024-05-17 大连理工大学 一种钾离子通道蛋白AlAKT1、其编码基因及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1100898A2 (en) * 1998-07-24 2001-05-23 Sagami Chemical Research Center Human proteins having hydrophobic domains and dnas encoding these proteins
EP1127073A1 (en) * 1998-11-03 2001-08-29 Smithkline Beecham Plc Human potassium channel (h-traak)
EP1144443A3 (en) * 1998-11-04 2001-12-05 Incyte Pharmaceuticals, Inc. Human membrane transport proteins
ATE394486T1 (de) * 1998-11-09 2008-05-15 Centre Nat Rech Scient Neue familie von säugetier-kaliumkanälen, ihre klonierung und ihre verwendung, besonders für das drogenscreening
US6670149B1 (en) * 1999-03-01 2003-12-30 Millennium Pharmaceuticals, Inc. TWIK-5 potassium channel nucleic acids and uses therefor
US6664373B1 (en) * 1999-03-01 2003-12-16 Millennium Pharmaceuticals, Inc. TWIK-5 potassium channel polypeptides and uses therefor
WO2001055321A2 (en) * 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies

Also Published As

Publication number Publication date
AU2001273239A1 (en) 2002-01-21
WO2002004520A2 (en) 2002-01-17
JP2004513618A (ja) 2004-05-13
EP1313854A2 (en) 2003-05-28
WO2002004520A3 (en) 2003-03-20

Similar Documents

Publication Publication Date Title
CA2415808A1 (en) Transporters and ion channels
CA2382015A1 (en) Membrane associated proteins
WO2001046258A2 (en) Transporters and ion channels
US20040224911A1 (en) Transporters and ion channels
CA2392961A1 (en) G-protein coupled receptors
US20040248251A1 (en) Receptors and membrane associated proteins
CA2399982A1 (en) G-protein coupled receptors
WO2002046415A2 (en) Polynucleotide and polypeptide sequences of putative transporters and ion channells
WO2002040541A2 (en) Transporters and ion channels
EP1326972A2 (en) Transporters and ion channels
CA2410084A1 (en) Transporters and ion channels
US20060035315A1 (en) Transporters and ion channels
CA2427085A1 (en) Transmembrane proteins
CA2374911A1 (en) G-protein coupled receptors
CA2443897A1 (en) Transporters and ion channels
CA2438206A1 (en) Transporters and ion channels
WO2001077174A2 (en) Human transporters and ion channels
US20030171275A1 (en) Transporters and ion channels
CA2413128A1 (en) Transporters and ion channels
US20030216310A1 (en) Transporters and ion channels
US20040053258A1 (en) Transporters and ion channels
US20040024183A1 (en) Transporters and ion channels
US20040014945A1 (en) Transporters and ion channels
US20040127683A1 (en) Transporters and ion channels
CA2422497A1 (en) Transporters and ion channels

Legal Events

Date Code Title Description
FZDE Dead